SI1079803T1 - Protein formulations - Google Patents

Protein formulations

Info

Publication number
SI1079803T1
SI1079803T1 SI9930678T SI9930678T SI1079803T1 SI 1079803 T1 SI1079803 T1 SI 1079803T1 SI 9930678 T SI9930678 T SI 9930678T SI 9930678 T SI9930678 T SI 9930678T SI 1079803 T1 SI1079803 T1 SI 1079803T1
Authority
SI
Slovenia
Prior art keywords
protein formulations
pharmaceutical formulations
osteoporosis
useful
concentration
Prior art date
Application number
SI9930678T
Other languages
English (en)
Slovenian (sl)
Inventor
Martin Billger
Mikael Brulls
Original Assignee
Nps Allelix Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Allelix Corp. filed Critical Nps Allelix Corp.
Publication of SI1079803T1 publication Critical patent/SI1079803T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SI9930678T 1998-04-28 1999-04-26 Protein formulations SI1079803T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9801495A SE9801495D0 (sv) 1998-04-28 1998-04-28 Protein formulationa
PCT/CA1999/000376 WO1999055353A2 (en) 1998-04-28 1999-04-26 Protein formulations
EP99917715A EP1079803B1 (en) 1998-04-28 1999-04-26 Protein formulations

Publications (1)

Publication Number Publication Date
SI1079803T1 true SI1079803T1 (en) 2005-02-28

Family

ID=20411122

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930678T SI1079803T1 (en) 1998-04-28 1999-04-26 Protein formulations

Country Status (24)

Country Link
US (1) US20050209144A1 (xx)
EP (1) EP1079803B1 (xx)
JP (2) JP4733267B2 (xx)
KR (1) KR100579872B1 (xx)
CN (1) CN1172658C (xx)
AT (1) ATE273693T1 (xx)
AU (2) AU766514B2 (xx)
BR (1) BR9909958A (xx)
CA (1) CA2329800C (xx)
CY (1) CY2006006I2 (xx)
DE (3) DE69919533T2 (xx)
DK (1) DK1079803T3 (xx)
ES (1) ES2224637T3 (xx)
FR (1) FR06C0032I2 (xx)
HK (1) HK1041218B (xx)
IL (1) IL139320A (xx)
LU (1) LU91281I2 (xx)
NL (1) NL300243I2 (xx)
NZ (1) NZ508269A (xx)
PT (1) PT1079803E (xx)
SE (1) SE9801495D0 (xx)
SI (1) SI1079803T1 (xx)
WO (1) WO1999055353A2 (xx)
ZA (1) ZA200006040B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
US20050032698A1 (en) * 2003-07-14 2005-02-10 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
WO2007059470A2 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
MX2009003569A (es) 2006-10-03 2009-08-25 Radius Health Inc Metodo de administracion de farmacos para la proteina anabolica osea.
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
FR2925333B1 (fr) * 2007-12-19 2012-04-13 Farid Bennis Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
JP2009091363A (ja) * 2008-11-21 2009-04-30 Asahi Kasei Pharma Kk Ｐｔｈの安定化水溶液注射剤
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US20140088014A1 (en) * 2011-06-07 2014-03-27 Asahi Kasei Pharma Corporation Freeze-dried preparation containing high-purity pth and method for producing same
CN103301058A (zh) * 2013-06-17 2013-09-18 深圳翰宇药业股份有限公司 一种特立帕肽注射用组合物及其制备方法和制剂
JP7019422B2 (ja) 2015-04-29 2022-02-15 ラジウス ファーマシューティカルズ，インコーポレイテッド 癌を治療するための方法
CN106309358A (zh) * 2015-06-29 2017-01-11 成都金凯生物技术有限公司 含有人甲状旁腺激素的药物组合物及其制备方法与用途
KR102557321B1 (ko) 2017-01-05 2023-07-18 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태
CN108333360A (zh) * 2017-01-19 2018-07-27 深圳市新产业生物医学工程股份有限公司 胃泌素释放肽前体稀释液及其应用和试剂盒
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
JP6577683B2 (ja) * 2017-09-22 2019-09-18 旭化成ファーマ株式会社 安定性に優れるテリパラチド含有液状医薬組成物
CN108159404B (zh) * 2018-01-05 2019-08-27 北京博康健基因科技有限公司 重组人甲状旁腺激素制剂及其制备方法
SG11202013177WA (en) 2018-07-04 2021-01-28 Radius Pharmaceuticals Inc Polymorphic forms of rad 1901-2hcl

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
DE3935738A1 (de) * 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5744444A (en) * 1989-10-27 1998-04-28 Haemopep Pharma Gmbh HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US5563122A (en) * 1991-12-09 1996-10-08 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
JP2662842B2 (ja) * 1991-12-09 1997-10-15 旭化成工業株式会社 パラサイロイドホルモンの安定化組成物
CA2145418A1 (en) * 1992-09-29 1994-04-14 John S. Patton Pulmonary delivery of active fragments of parathyroid hormone
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
JPH09157294A (ja) * 1995-06-15 1997-06-17 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
DE19538687A1 (de) * 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsformen enthaltend Parathormon
JP4053107B2 (ja) * 1996-02-01 2008-02-27 中外製薬株式会社 血小板減少症の予防剤および治療剤
US5964807A (en) * 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa

Also Published As

Publication number Publication date
HK1041218A1 (en) 2002-07-05
NZ508269A (en) 2003-12-19
AU3591699A (en) 1999-11-16
CA2329800C (en) 2004-06-15
FR06C0032I2 (fr) 2007-04-27
EP1079803B1 (en) 2004-08-18
SE9801495D0 (sv) 1998-04-28
AU2004200156A1 (en) 2004-02-12
JP2011105739A (ja) 2011-06-02
JP5753692B2 (ja) 2015-07-22
KR20010052276A (ko) 2001-06-25
CN1319003A (zh) 2001-10-24
CA2329800A1 (en) 1999-11-04
CY2006006I1 (el) 2009-11-04
WO1999055353A2 (en) 1999-11-04
DE69919533D1 (de) 2004-09-23
NL300243I2 (nl) 2007-02-01
US20050209144A1 (en) 2005-09-22
FR06C0032I1 (xx) 2006-11-24
DE69919533T2 (de) 2005-09-08
ZA200006040B (en) 2002-01-28
CN1172658C (zh) 2004-10-27
LU91281I2 (fr) 2006-12-19
JP2002512973A (ja) 2002-05-08
AU766514B2 (en) 2003-10-16
ES2224637T3 (es) 2005-03-01
KR100579872B1 (ko) 2006-05-12
DE122006000057I2 (de) 2009-11-05
EP1079803A2 (en) 2001-03-07
IL139320A0 (en) 2001-11-25
JP4733267B2 (ja) 2011-07-27
BR9909958A (pt) 2000-12-26
NL300243I1 (nl) 2006-12-01
AU2004200156B2 (en) 2005-12-15
HK1041218B (zh) 2005-03-18
CY2006006I2 (el) 2009-11-04
IL139320A (en) 2007-06-17
ATE273693T1 (de) 2004-09-15
DE122006000057I1 (de) 2007-01-04
WO1999055353A3 (en) 2000-01-13
PT1079803E (pt) 2004-11-30
DK1079803T3 (da) 2004-11-22

Similar Documents

Publication Publication Date Title
FR06C0032I1 (xx)
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
EA200501744A1 (ru) Пептид (варианты), содержащая его композиция и лекарственный препарат для профилактики и лечения астеросклероза
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
AP9801269A0 (en) Prostaglandin agonists.
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
WO2001083722A3 (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
IL164317A0 (en) Statin therapy for enhancing cognitive maintenance
GB9823515D0 (en) Agent for the treatment of osteoporosis
HUP0100634A2 (hu) Pentaeritrit-tetranitrátot tartalmazó gyógyászati készítmények
ATE170191T1 (de) Physiologisch aktive peptide und den calcium- metabolismus regulierende arzneimittel, die genannte peptide als wirkungsvollen bestandteil enthalten
IT1307866B1 (it) Composizioni farmaceutiche contenenti inibitori dell'ormone dellacrescita o loro frammenti biologicamente attivi per il trattamento
UA30798A (uk) Спосіб пролонгованої терапії онкологічних хворих